Delivering Accuracy, Consistency and Security for LifeNet Health
Delivering Accuracy, Consistency and Security for LifeNet Health
3 Pages1 | © ARANZ Medical 2017 | Case study | LifeNet Health In the largest and most rigorous randomized control trial to date for human Advanced Dermal Matrix (ADM) products, DermACELL ® AWM™ (Advanced Wound Management) demonstrated superior rates of healing and wound closure in diabetic foot ulcers. In 2013, LifeNet Health began a 13-site interventional study of its DermACELL product with 203 patients (168 diabetic foot ulcers a
